# A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers

> **NCT00839891** · PHASE1 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 112 (actual)

## Conditions studied

- Torsades de Pointes

## Interventions

- **DRUG:** VI-0521

## Key facts

- **NCT ID:** NCT00839891
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2010-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00839891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00839891, "A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00839891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*